Search

everythinglearnresearchcommunity

for

Search:↓

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.

Hormonal status from androgen deprivation therapy may affect COVID-19 severity in men.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Gene mutations can cause problems in male genital development.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Androgens increase growth factors in skin cells, which may lead to acne.

The study suggests that a specific gene variation and higher gene activity are linked to increased baldness in Egyptian men.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Having enough iron improves the effectiveness of a specific hair loss treatment in women.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

New finasteride solution effectively reduces baldness-causing hormone, potentially with fewer side effects.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

DHT affects hair follicle cells by changing microRNA levels, leading to less cell growth and more cell death.

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Bleaching hair damages protein structure, especially keratin, leading to weakened hair.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.

The conclusion is that hair supplement ingredients may be unsafe and should be disclosed and proven safe before use.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

Alopecia areata in children shows varied symptoms and may involve nails, needing further evaluation for other health issues.

Anabolic steroids and SARMs can cause serious liver damage.